Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovirus Infections | 2 | 2024 | 14 | 1.520 |
Why?
|
| Encephalomyocarditis virus | 2 | 2024 | 15 | 1.510 |
Why?
|
| ADAM Proteins | 2 | 2024 | 34 | 1.500 |
Why?
|
| Membrane Proteins | 2 | 2024 | 850 | 1.020 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2024 | 16 | 0.900 |
Why?
|
| Myocarditis | 1 | 2024 | 60 | 0.840 |
Why?
|
| Interferon Type I | 1 | 2024 | 169 | 0.790 |
Why?
|
| Disease Resistance | 1 | 2019 | 23 | 0.620 |
Why?
|
| Immunity, Innate | 1 | 2024 | 774 | 0.590 |
Why?
|
| Schistosomiasis mansoni | 4 | 2009 | 4 | 0.540 |
Why?
|
| Liver Diseases, Parasitic | 3 | 2009 | 4 | 0.410 |
Why?
|
| Interleukin-17 | 5 | 2009 | 88 | 0.360 |
Why?
|
| Strongylida Infections | 2 | 2008 | 5 | 0.330 |
Why?
|
| Ovum | 4 | 2009 | 61 | 0.300 |
Why?
|
| Mice, Knockout | 4 | 2024 | 1997 | 0.290 |
Why?
|
| Cytokines | 2 | 2008 | 912 | 0.240 |
Why?
|
| Liver | 1 | 2008 | 796 | 0.220 |
Why?
|
| Mice | 8 | 2024 | 10301 | 0.210 |
Why?
|
| HEK293 Cells | 1 | 2024 | 587 | 0.190 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 411 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 3236 | 0.180 |
Why?
|
| Animals | 9 | 2024 | 19667 | 0.160 |
Why?
|
| Nematospiroides dubius | 2 | 2008 | 4 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 88 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2019 | 126 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2024 | 2901 | 0.140 |
Why?
|
| Schistosoma mansoni | 2 | 2008 | 6 | 0.140 |
Why?
|
| Cell Line | 2 | 2019 | 1984 | 0.130 |
Why?
|
| Models, Biological | 1 | 2019 | 1143 | 0.110 |
Why?
|
| Dengue Virus | 1 | 2012 | 95 | 0.100 |
Why?
|
| Viral Envelope Proteins | 1 | 2012 | 100 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2012 | 178 | 0.090 |
Why?
|
| Antibodies, Viral | 1 | 2012 | 292 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 529 | 0.090 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 71 | 0.080 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2008 | 1 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2008 | 10 | 0.080 |
Why?
|
| Interleukin-23 | 1 | 2008 | 19 | 0.080 |
Why?
|
| Epithelium | 1 | 2008 | 96 | 0.080 |
Why?
|
| Mesoderm | 1 | 2008 | 81 | 0.080 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2008 | 3 | 0.070 |
Why?
|
| Interleukin-1 | 1 | 2008 | 157 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 836 | 0.070 |
Why?
|
| Immune Tolerance | 1 | 2008 | 172 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2008 | 179 | 0.070 |
Why?
|
| Schistosomiasis | 1 | 2007 | 4 | 0.070 |
Why?
|
| Proteomics | 1 | 2008 | 264 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 227 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 207 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 588 | 0.060 |
Why?
|
| Dendritic Cells | 1 | 2008 | 515 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 2007 | 551 | 0.060 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 621 | 0.060 |
Why?
|
| Macrophages | 1 | 2008 | 1015 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 2051 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 1118 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2008 | 2095 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 2008 | 215 | 0.030 |
Why?
|
| Humans | 3 | 2019 | 59454 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 1482 | 0.030 |
Why?
|
| Female | 3 | 2009 | 30766 | 0.030 |
Why?
|
| Antibody-Dependent Enhancement | 1 | 2012 | 4 | 0.030 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2012 | 16 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2012 | 47 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2012 | 118 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2012 | 103 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2012 | 235 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 228 | 0.020 |
Why?
|
| Physical Chromosome Mapping | 1 | 2009 | 4 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2009 | 22 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 105 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2009 | 93 | 0.020 |
Why?
|
| Granuloma | 1 | 2009 | 41 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2008 | 16 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 39 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2008 | 83 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2008 | 95 | 0.020 |
Why?
|
| Species Specificity | 1 | 2009 | 329 | 0.020 |
Why?
|
| Mesentery | 1 | 2008 | 15 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 217 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2008 | 127 | 0.020 |
Why?
|
| Antigens, Helminth | 1 | 2008 | 9 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2008 | 145 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 142 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 171 | 0.020 |
Why?
|
| Colitis | 1 | 2008 | 74 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 584 | 0.020 |
Why?
|
| Interleukins | 1 | 2007 | 80 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 559 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 245 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 461 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 720 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 676 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 1138 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 1469 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 858 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2008 | 1553 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 1099 | 0.010 |
Why?
|
| Male | 2 | 2009 | 27784 | 0.010 |
Why?
|